Trial intelligence / Profile preview

Abilify in Bipolar Depression

NCT00363337Phase 4Completed

Sponsor
Lindner Center of HOPE
Start
Aug 2006
Primary completion
Mar 2009
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of aripiprazole in bipolar disorder (BD), sponsored by Lindner Center of HOPE. Started Aug 2006; status: completed.

02

Drugs

aripiprazole
03

Conditions

bipolar disorder (BD)

Beyond the preview

Go deeper on NCT00363337.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00363337.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call